IOBT Q3 2021 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$18M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$7M

Net Income

-$4M

EPS (Diluted)

$-0.17

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$483,000

Balance Sheet

Total Assets

$52M

Total Liabilities

$34M

Stockholders' Equity

$18M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$7M	-$3M	-105.2%
Net Income	-$4M	-$3M	-27.9%